German Society of Immunology Study Group Biology of B Lymphocytes. 13 th B Cell Forum. February 19-21, Hitzacker, Elbe
|
|
- Tamsin Cook
- 8 years ago
- Views:
Transcription
1 German Society of Immunology Study Group Biology of B Lymphocytes 13 th B Cell Forum February 19-21, 2015 Hitzacker, Elbe
2 CONTENT Program/General Information... 1 Program... 2 Titles Poster Session... 7 Participants Abstracts - Oral Presentations Session I: B cell memory, germinal centers and T follicular helper cells. 15 Session IIa: B cell development, signaling and activation Session IIb: B cell development, signaling and activation Session III: B cell ontogeny and dynamics of B cell homeostasis Session IVa: Plasma cells, antibody production and autoimmunity Session IVb: Plasma cells, antibody production and autoimmunity Abstracts - Poster Presentations B cell memory, germinal centers and T follicular helper cells Methods B cell development, signaling and activation B cell ontogeny and dynamics of B cell homeostasis Plasma cells, antibody production and inflammation Sponsors... 96
3 PROGRAM/GENERAL INFORMATION MEETING SCHEDULE February, 19: Registration will start at 15:00 February 21: Farewell Lunch / Departure at 11:30 ORAL PRESENTATIONS All talks will be 10 minutes plus 5 minutes discussion (exception: keynote speakers) Please hand in your PowerPoint presentation on a USB stick before or during the break before your session. Sorry, no personal laptops can be used for presentation. POSTER PRESENTATIONS Posters should be printed in size A0 Posters should be mounted on February 19 between 15:00 and 19:00 Poster presentation will begin on February 20 at 18:30 1
4 PROGRAM Thursday, February 19, :00 19:00 Registration and Poster Setup 15:30 16:50 Get-together (coffee and cake) 16:55 Welcome (Jürgen Wienands) Session I: B cell memory, germinal centers and T follicular helper cells Chair: Thomas Winkler / Hyun-Dong Chang 17:00 Andreas Hutloff, Berlin ICOS maintains the T follicular helper cell phenotype by downregulating Krüppel-like factor 2 17:15 Michael Meyer-Hermann, Braunschweig Overcoming the dichotomy of quantity and quality of germinal centre output 17:30 Thomas Winkler, Erlangen Adoptive immunotherapy with memory B cells - A Phase I/IIa clinical trial for patients after hematopoietic stem cell transplantation 17:45 18:10 Break Keynote Lecture Chair: Rudolf Manz 18:10 19:10 Surprise Speaker 19:30 Dinner (Buffet) 2
5 Friday, February 20, :00 8:45 Breakfast Session IIa: B cell development, signaling and activation Chair: Jürgen Wienands / Ari Waisman 8:45 Jianying Yang, Freiburg The dissociation activation model of B cell activation 9:00 Dirk Mielenz, Erlangen Quantification of surface receptor clustering by flow cytometry 9:15 Bernd Schröder, Kiel Processing of CD74 by the intramembrane protease SPPL2a is critical for PI3K/Akt signaling in developing B cells 9:30 Christian Kosan, Jena The transcription factor 'Myc interacting zinc finger protein 1' is a key regulator for B cell development and activation 9:45 Kristin Schröder, Lübeck The anaphylatoxin C5a drives pathogenic IgG autoantibody formation in an active model of experimental epidermolysis bullosa acquisita 10:00 Coffee Break 3
6 Session IIb: B cell development, signaling and activation Chair: Andreas Radbruch / Rudi Hendriks 10:30 Edgar Serfling, Würzburg The Transcription Factor NFATc1 Affects the Fate of Peripheral B Cells by Controlling their Aerobic Glycolysis 10:45 Glen Pearce, Dresden The Role of SWAP70 in DNA Repair and Cancer 11:00 Alexander Weber, Tübingen Oncogenic MyD88 mutations in B cell malignancies 11:15 Jürgen Wienands, Göttingen Absence of CIN85 expression presents with X-chromosome-linked antibody deficiency in humans 11:30 Nadine Hövelmeyer, Mainz Over-Expression of an Alternative Splice Variant of the Negative NFkappaB Regulator CYLD Leads to the Development of B-CLL in Mice. 12:00 Lunch Session III: B cell ontogeny and dynamics of B cell homeostasis Chair: Edgar Meinl / Lars Nitschke 14:00 Franziska Fettke, Magdeburg The effect of pregnancy hormones and trophoblastderived factors on IL-10 producing regulatory B cells 14:15 Alice Muggen, Rotterdam Dynamics in B cell subset and B cell repertoire distribution during human aging 14:30 Martina Przekopowitz, Essen Ontogeny, differentiation and function of human mature CD5+ B cells 14:45 Katharina Bröker, Lübeck Non-classical complement activation regulates the peritoneal B1 cell compartment 15:00 Martin Lipp, Berlin The transcriptional coactivator Bob1 regulates the development of TFH cells 4
7 15:30 17:30 Elbe /Hitzacker Walk 17:30 Meeting Study Group Biology of B Lymphocytes 18:30 Poster Session and Dinner (Buffet) 20:45 Concession of poster award 21:00 Party 5
8 Saturday, February 21, :00 8:45 Breakfast Session IVa: Plasma cells, antibody production and autoimmunity Chair: Hans-Martin Jäck / Andreas Hutloff 8:45 Edgar Meinl, München The immunoregulator soluble TACI is released by ADAM10 and reflects B-cell activation in autoimmunity 9:00 Odilia Corneth, Rotterdam Dysregulated Btk expression in peripheral blood B lymphocytes in systemic autoimmune disease 9:15 Simon Eschweiler, Lübeck Development of differentially glycosylated antibodies 9:30 Hans-Martin Jäck, Erlangen How MicroRNAs Control Plasma Cells 9:45 Break Session IVb: Plasma cells, antibody production and autoimmunity Chair: Falk Nimmerjahn / Claudia Berek 10:15 Stefanie Schmidt, Berlin Towards a synthetic niche for memory plasma cells 10:30 Britta Frehse, Lübeck Increased c-mpl dependent megakaryopiesis controls plasma cell formation in lupus 10:45 Claudia Berek, Berlin Eosinophils promote the generation and maintenance of IgA plasma cells 11:30 13:00 Farewell Lunch /Departure 6
9 TITLES POSTER SESSION 1. Caren Bartsch, Göttingen Regulation of intracellular B cell antigen receptor signalling events by a recombinant soluble FcγIIB receptor 2. Alexander Beller, Berlin Development and survival of IgA + plasma cells in peyer s patches of eosinophil-deficient mice 3. Julia Bischof, Lübeck Establishment of an infrastructure for the analysis of the B cell immune repertoire: application to the analysis of B cell subpopulations in auto-immune blistering dermatoses 4. Kathrin Brenker, Freiburg Photo-Caging of the Spleen Tyrosine Kinase 5. Katharina Bröker, Lübeck Non-classical complement activation regulates the peritoneal B1 cell compartment 6. Eva-Maria Cox, Mainz B cell specific overexpression of Akt leads to expansion of marginal zone B cells 7. Marjolein de Bruijn, Rotterdam Regulatory role for Tec Kinase in B cell immunity 8. Kai Dittman, Göttingen mb1-cre-controlled ablation of Shp2 (Ptpn11) causes metachondromatosis 9. Asmaa El Beidaq, Lübeck Can diet affect the B cell receptor repertoire diversity in mice? 10. Niklas Engels, Göttingen The extracellular membrane-proximal domain of membrane-bound IgE restricts surface expression and signaling of mige-bcrs 7
10 11. Simon Eschweiler, Lübeck The development of pro-inflammatory agalactosylated IgG antibodies is dependent on the pro-inflammatory cytokines IFN-γ and IL Stephanie Gläsener, Hannover Human neonatal B cell subpopulations are intrinsically immature 13. Matthias Hahn, Mainz Over-expression of an alternative splice variant of the negative NFκB regulator CYLD leads to the development of B-CLL in mice 14. Juliane Hobusch, Lübeck Allergen-specific immunotherapy (SIT) induce sialylated immunesuppressive IgG antibodies 15. Bimba Hoyer, Berlin Differential B and plasma cell homing mechanisms in inflamed kidneys of NZB/W F1 mice 16. Andreas Hutloff, Berlin Local T/B cooperation in inflamed tissues is supported by a unique population of B helper T cells distinct from T follicular helper cells 17. Kathrin Kläsener, Freiburg B cell activation involves nanoscale receptor reorganizations and inside-out signaling by Syk 18. Alexei Leliavski, Lübeck Identifying molecular pathways that govern the development of tolerogenic plasma cells in vivo 19. Christopher Link, Lübeck The impact of IL-10 on IgE-mediated food allergy 20. Anna Lollies, Essen The AP-1 transcription factor BATF3 is aberrantly expressed in classical Hodgkin lymphoma and contributes to tumor cell survival and proliferation 21. Dirk Mielenz, Erlangen Quantification of surface receptor clustering by flow cytometry 8
11 22. Lavanya Mokada Gopal, Erlangen Functional characterization of STAT6-regulated genes in B cells and their impact on the Germinal Centre response 23. Alice Muggen, Rotterdam Dynamics in B cell subset and B cell repertoire distribution during human aging 24. Zane Orinska, Borstel CD37-specific monoclonal antibodies as a tool to target B cells 25. Lamia Özgör, Erlangen Effects of Epratuzumab, a monoclonal antibody targeting human CD22, on B cell function in human CD22 knock-in mice 26. Katharina Pracht, Erlangen Function of mir-148a in mature plasma cells 27. Dorothea Reimer, Erlangen Regulation of Lymphocyte Adhesion and Migration by Swiprosin-1/ EFhd2 28. Marta Rizzi, Freiburg Treatment with tofacitinib alters human B lymphocyte development and function 29. Julia Schmid, Erlangen mir-148a a key regulator in plasma cell differentiation? 30. Stefanie Schmidt, Berlin Towards a synthetic niche for memory plasma cells 31. Maren Schmidt, Göttingen Global transcriptional amplification by Myc in B lymphocytes: an assay to detect selective up- and downregulation of specific Myc target genes. 32. Verena Schmitt, Erlangen IL-36α is expressed in B lymphocytes and activates synovial like fibroblasts 9
12 33. Heike Schmitt, Erlangen The role of Siglec-H in autoimmunity and during infection 34. Kristin Schröder, Lübeck The anaphylatoxin C5a drives pathogenic IgG auto-antibody formation in an active model of experimental epidermolysis bullosa acquisita 35. Wolfgang Schuh, Erlangen The role of KLF2 and KLF4 in generation, homing and survival of plasma cells in vitro and in vivo 36. Kathrin Schulz, Göttingen Absence of CIN85 expression presents with X-chromosome-linked antibody deficiency in humans 37. Simar Pal Singh, Rotterdam Characterization of novel mouse cell lines to study the role of B-cell receptor signaling in development of Chronic Lymphocytic Leukemia 38. Merle Stein, Erlangen Function of the protein Swiprosin-2/EFhd1 in early B lymphocyte development 39. Sandra Tretow, Berlin Molecular interference of vitamin A and D receptors in B lymphocytes 10
13 PARTICIPANTS NAME CITY ORGANISATION Bartsch Caren Göttingen University Hospital Göttingen Beller Alexander Berlin DRFZ Berlin Berek Claudia Berlin DRFZ Berlin Bischof Julia Lübeck University of Lübeck Brandl Carolin Erlangen FAU Erlangen - Nürnberg carolin.brandl@fau.de Brenker Kathrin Freiburg MPI of Immunology and Epigenetics kathrin.brenker@gmail.com Bröker Katharina Lübeck University of Lübeck Katharina.Broeker@uksh.de Cavallari Marco Freiburg University of Freiburg Chang Hyun-Dong Freiburg DRFZ Berlin chang@drfz.de Corneth Odilia Rotterdam Erasmus MC Rotterdam o.corneth@erasmusmc.nl Cox Eva-Maria Mainz University of Mainz cox@uni-mainz.de de Bruijn Marjolein Rotterdam Erasmus MC Rotterdam j.w.debruijn@erasmusmc.nl Dittmann Kai Göttingen University of Göttingen kdittma@gwdg.de Ehlers Marc Lübeck University of Lübeck marc.ehlers@uk-sh.de El Beidaq Asmaa Lübeck University of Lübeck asmaaelbeidaq@gmail.com Engelke Michael Göttingen University of Göttingen mengelk@gwdg.de Engels Niklas Göttingen University of Göttingen nengels@gwdg.de Eschweiler Simon Lübeck University of Lübeck Simon.Eschweiler@uksh.de Fettke Franziska Magdeburg Otto-von-Guericke University franziska.fettke@med.ovgu.de Figge Julia Lübeck University of Lübeck julia.figge@uksh.de Frehse Britta Lübeck University of Lübeck Britta.Frehse@yahoo.com Gläsener Stephanie Hannover Hannover Medical School Hahn Matthias Mainz University of Mainz hahn002@uni-mainz.de Heine Guido Berlin University Hospital Charité guido.heine@charite.de Hendriks Rudi Rotterdam Erasmus MC Rotterdam r.hendriks@erasmusmc.nl Hitzing Christoffer Göttingen University Hospital Göttingen C.Hitzing@googl .com Hobusch Juliane Lübeck University of Lübeck juliane.hobusch@uksh.de Hofmann Katharina Lübeck University of Lübeck katharina.hofmann@outlook.com Hövelmeyer Nadine Mainz University of Mainz hoevelme@uni-mainz.de Hoyer Bimba Berlin University Hospital Charité hoyer@drfz.de Hutloff Andreas Berlin DRFZ Berlin hutloff@drfz.de Jäck Hans-Martin Erlangen FAU Erlangen - Nürnberg hjaeck@gmail.com Jessberger Rolf Dresden TU Dresden rolf.jessberger@tu-dresden.de Karsten Christian Lübeck University of Lübeck christian.karsten@uksh.de Kläsener Kathrin Freiburg University of Freiburg caren.bartsch@med.unigoettingen.de marco.cavallari@bioss.unifreiburg.de Glaesener.Stephanie@mhhannover.de kathrin.klaesener@bioss.unifreiburg.de Klopp Kirstin Biozol Biozol Diagnostica K.klopp@biozol.de Kosan Christian Jena Friedrich-Schiller-University Jena christian.kosan@uni-jena.de Kube Dieter Göttingen Universitätsmedizin Göttingen dkube@med.uni-goettingen.de Küppers Ralf Essen University of Duisburg-Essen ralf.kueppers@uk-essen.de Lahmann Annette Berlin DRFZ Berlin annette.lahmann@drfz.de 11
14 NAME CITY ORGANISATION Langhans Kristina Borstel Research Center Borstel Leliavski Alexei Lübeck University of Lübeck Leypoldt Frank Kiel UKSH Kiel Lilienthal Gina-Maria Lübeck University of Lübeck Link Christopher Lübeck University of Lübeck Lipp Martin Berlin Max-Delbrück-Centrum Berlin Lollies Anna Essen University Hospital Essen Manz Rudolf Lübeck University of Lübeck Meinl Edgar München LMU München Meng Lingzhang Lübeck University of Lübeck Meyer- Hermann Michael Braunschweig HZI Mielenz Dirk Erlangen FAU Erlangen - Nürnberg dmielenz@molmed.uni-erlangen.de Mokada Gopal Lavanya Erlangen FAU Erlangen lavanya.lyla@gmail.com Muggen Alice Rotterdam Erasmus MC Rotterdam a.muggen@erasmusmc.nl Nimmerjahn Falk Erlangen FAU Erlangen - Nürnberg falk.nimmerjahn@fau.de Nitschke Lars Erlangen FAU Erlangen - Nürnberg lars.nitschke@fau.de Orinska Zane Borstel Research Center Borstel zorinska@fz-borstel.de Özgör Lamia Erlangen FAU Erlangen - Nürnberg Lamia.Oezgoer@fau.de Pearce Glen Dresden TU Dresden glen.pearce@tu-dresden.de Petry Janina Lübeck University of Lübeck janina.petry@web.de Piedavent- Salomon Melanie Sony Sony Europe Limited Pillai Saravanan Rotterdam Erasmus MC Rotterdam s.yuvaraj@erasmusmc.nl Pracht Katharina Erlangen University Hospital Erlangen katharina.pracht@freenet.de Przekopowitz Martina Essen University Duisburg - Essen Radbruch Andreas Berlin DRFZ Berlin radbruch@drfz.de Rahmöller Johann Lübeck University of Lübeck johann.rahmoeller@gmail.com Reimer Dorothea Erlangen University Hospital Erlangen dreimer@molmed.uni-erlangen.de Reth Michael Freiburg Albert-Ludwigs-University Freiburg michael.reth@bioss.uni-freiburg.de, officer@ie-freiburg.mpg.de Rizzi Marta Freiburg University Hospital Freiburg marta.rizzi@uniklinik-freiburg.de Schepp Johanna Freiburg Albert-Ludwigs-University Freiburg Schmid Julia Erlangen University Hopsital Erlangen jschmid@molmed.uni-erlangen.de Schmidt Stefanie Berlin DRFZ Berlin s.schmidt@drfz.de Schmidt Maren Göttingen University of Göttingen Schmitt Verena Erlangen FAU Erlangen - Nürnberg verena.schmitt@uk-erlangen.de Schmitt Heike Erlangen FAU Erlangen - Nürnberg heike.schmitt@fau.de Schmücker Anne Preprotech Peprotech GmbH aschmuecker@peprotech.de Schramm Gabriele Borstel Research Center Borstel gschramm@fz-borstel.de Schröder Kristin Lübeck University of Lübeck kristin.schroeder@uksh.de Schröder Bernd Kiel Christian-Albrechts-University Kiel Schubert Desirée Freiburg University Hospital Freiburg baschroeder@biochem.uni-kiel.de melanie.piedaventsalomon@eu.sony.com martina.przekopowitz@stud.unidue.de johanna.schepp@uniklinikfreiburg.de maren.schmidt@med.unigoettingen.de desiree.schubert@uniklinikfreiburg.de 12
15 NAME CITY ORGANISATION Schuh Wolfgang Erlangen FAU Erlangen - Nürnberg wschuh@molmed.uni-erlangen.de Schulz Kathrin Göttingen University of Göttingen kathrin.schulz@med.unigoettingen.de Schumacher Anne Magdeburg Otto-von-Guericke University anne.schumacher@med.ovgu.de Serfling Edgar Wuerzburg University of Würzburg serfling.e@mail.uni-wuerzburg.de Singh Simar Pal Rotterdam Erasmus MC Rotterdam s.palsingh@erasmusmc.nl Stein Merle Erlangen University Hospital Erlangen mstein@molmed.uni-erlangen.de Tiburzy Benjamin Biolegend Biolegend btiburzy@biolegend.com Treptow Sandra Berlin TU Berlin sandra.treptow@charite.de Waisman Ari Mainz University of Mainz waisman@uni-mainz.de Weber Alexander Tübingen University of Tübingen alexander.weber@uni-tuebingen.de Weiss Siegfried Braunschweig HZI siegfried.weiss@helmholtz-hzi.de Wienands Jürgen Göttingen University of Göttingen jwienan@gwdg.de Winkler Thomas Erlangen FAU Erlangen - Nürnberg thomas.winkler@fau.de Wolfram Udo Milteny Miltenyi Biotec bettinar@miltenyibiotec.de Yang Jianying Freiburg MPI of Immunology and Epigenetics yang@immunbio.mpg.de Zenclussen Ana Magdeburg Otto-von-Guericke University ana.zenclussen@med.ovgu.de 13
16
17
18
19
20 THIS EVENT IS SPONSORED BY,
21
2 nd Forum B Cell Biology
Preliminary Program 2 nd Forum B Cell Biology Potsdam, 11-13 March 2004 local organizing committee: Claudia Berek Hilmar Frank Falk Hiepe Rudolf A. Manz Marion Nowak Petra Starke Andreas Radbruch Christine
More information3 rd B Cell Forum March 17 to 19, 2005 Bad Breisig, Germany Germany. Germany
3 rd B Cell Forum March 17 to 19, 2005 Bad Breisig, Germany Germany Germany Preliminary Program 3 rd Forum B Cell Biology Bad Breisig, 17-19 March 2005 Organizing committee: Ari Waisman Markus Müschen
More informationPROGRAMM. 1. Forum Biologie der B- Lymphozyten" Tagungsstätte: in Titisee 13.-16. März, 2002
PROGRAMM 1. Forum Biologie der B- Lymphozyten" in Titisee 13.-16. März, 2002 Tagungsstätte: Hotel Brugger am See Strandbadstr. 14 79822 Titisee-Neustadt Telefon 07651/8010 Telefax 07651/8238 E-Mail: hotel.brugger@t-online.de
More informationGerman Society of Immunology Study Group Biology of B Lymphocytes
German Society of Immunology Study Group Biology of B Lymphocytes German Society of Immunology Study Group Biology of B Lymphocytes 11 th B Cell Forum February 25-27, 2013 Schluchsee Hochschwarzwald Organizing
More informationspecific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins
Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes
More informationB Cells and Antibodies
B Cells and Antibodies Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School Lecture outline Functions of antibodies B cell activation; the role of helper T cells in antibody production
More informationHow do plasma cells survive
How do plasma cells survive Claudia Berek Deutsches Rheuma Forschungs Zentrum, Berlin Institut der Leibniz Gemeinschaft Immune response Naive B cell Peripheral lymphoid organs Memory B cell Germinal T
More informationHUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13
SECTION 13 HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES CONTACT INFORMATION Jason Cyster, PhD (Email) READING Basic Immunology: Functions and Disorders of the Immune System. Abbas,
More informationMicrobiology AN INTRODUCTION EIGHTH EDITION
TORTORA FUNKE CASE Microbiology AN INTRODUCTION EIGHTH EDITION Differentiate between innate and acquired immunity. Chapter 17 Specific Defenses of the Host: The Immune Response B.E Pruitt & Jane J. Stein
More informationSummer School 2011 Berlin SFB Transregio 19
Summer School 2011 Berlin SFB Transregio 19 27th October 29th October 2011 Molecular Mechanisms and Consequences of Inflammatory Cardiomyopathy: State of the Art and Future Challenges Welcome Address
More informationB cell activation and Humoral Immunity
B cell activation and Humoral Immunity Humoral immunity is mediated by secreted antibodies and its physiological function is defense against extracellular microbes (including viruses) and microbial exotoxins.
More informationPulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic
Pulling the Plug on Cancer Cell Communication Stephen M. Ansell, MD, PhD Mayo Clinic Why do Waldenstrom s cells need to communicate? Waldenstrom s cells need activating signals to stay alive. WM cells
More informationActivation and effector functions of HMI
Activation and effector functions of HMI Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 25 August 2015 ว ตถ ประสงค หล งจากช วโมงบรรยายน แล วน กศ กษาสามารถ
More informationMidwinter Conference 2015 January 17-22 Seefeld, Tyrol CONFERENCE PROGRAM. midwinter2015.org. Sponsored by
Midwinter Conference 2015 January 17-22 Seefeld, Tyrol CONFERENCE PROGRAM Sponsored by SATURDAY, 17 January 18.00-19.00 Keynote lecture Richard Flavell Sponsored by 19.00 Welcome Reception Hosted by SUNDAY,
More informationThe Immune System: A Tutorial
The Immune System: A Tutorial Modeling and Simulation of Biological Systems 21-366B Shlomo Ta asan Images taken from http://rex.nci.nih.gov/behindthenews/uis/uisframe.htm http://copewithcytokines.de/ The
More informationAutoimmunity and immunemediated. FOCiS. Lecture outline
1 Autoimmunity and immunemediated inflammatory diseases Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline Pathogenesis of autoimmunity: why selftolerance fails Genetics of autoimmune diseases Therapeutic
More informationThe immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor
The immune system Basophil Neutrophil Bone marrow Eosinophil Myeloid progenitor Dendritic cell Pluripotent Stem cell Lymphoid progenitor Platelets Bone marrow Thymus NK cell T-cell B-cell Spleen Cancer
More informationB Cell Generation, Activation & Differentiation. B cell maturation
B Cell Generation, Activation & Differentiation Naïve B cells- have not encountered Ag. Have IgM and IgD on cell surface : have same binding VDJ regions but different constant region leaves bone marrow
More informationA Genetic Analysis of Rheumatoid Arthritis
A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.
More informationCancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center
Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center Bodnar s Law Simple Things are Important Very Simple Things are Very Important
More informationChapter 43: The Immune System
Name Period Our students consider this chapter to be a particularly challenging and important one. Expect to work your way slowly through the first three concepts. Take particular care with Concepts 43.2
More informationUses of Flow Cytometry
Uses of Flow Cytometry 1. Multicolour analysis... 2 2. Cell Cycle and Proliferation... 3 a. Analysis of Cellular DNA Content... 4 b. Cell Proliferation Assays... 5 3. Immunology... 6 4. Apoptosis... 7
More informationUpdate in Hematology Oncology Targeted Therapies. Mark Holguin
Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning
More informationLauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?
Hello, I m Lauren Berger and I m the Senior Director of Patient Services Programs at The Leukemia & Lymphoma Society. I m pleased to welcome Dr. Rebecca Elstrom. Dr. Elstrom is an Assistant Professor in
More information2) Macrophages function to engulf and present antigen to other immune cells.
Immunology The immune system has specificity and memory. It specifically recognizes different antigens and has memory for these same antigens the next time they are encountered. The Cellular Components
More informationAbout B Cell Lymphomas Groupmeeting Klipp/Spang, December 09 2002 Dennis Kostka Max-Planck-Institute for Molecular Genetics Computational Molecular Biology Berlin 1 Overview Short History of Lymphoma Classification
More informationLEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials
LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational
More informationVitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model
Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model Robyn Balden & Farida Sohrabji Texas A&M Health Science Center- College of Medicine ISC
More informationCONTENT. Chapter 1 Review of Literature. List of figures. List of tables
Abstract Abbreviations List of figures CONTENT I-VI VII-VIII IX-XII List of tables XIII Chapter 1 Review of Literature 1. Vaccination against intracellular pathogens 1-34 1.1 Role of different immune responses
More informationTargeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
More informationDFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Cancer Therapy April 23rd-26th, 2015 Villa La Collina Cadenabbia (Co), Italy Program Committee Anja Bosserhoff, Erlangen (Chair)
More informationT Cell Maturation,Activation and Differentiation
T Cell Maturation,Activation and Differentiation Positive Selection- In thymus, permits survival of only those T cells whose TCRs recognize self- MHC molecules (self-mhc restriction) Negative Selection-
More informationCD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy
CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy Joseph M. Tuscano, Jason Kato, David Pearson, Chengyi Xiong, Laura Newell, Yunpeng Ma, David R. Gandara,
More informationVersion 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen
Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical
More informationHow To Expand Hematopoietic Stem Cells
Purification and Expansion of Hematopoietic Stem Cells Based on Proteins Expressed by a Novel Stromal Cell Population Our bodies are constantly killing old, nonfunctional, and unneeded cells and making
More informationLYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons
LYMPHOMA BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons Normal development of lymphocytes Lymphocyte proliferation and differentiation:
More informationDendritic Cells: A Basic Review *last updated May 2003
*last updated May 2003 Prepared by: Eric Wieder, PhD MD Anderson Cancer Center Houston, TX USA What is a dendritic cell? Dendritic cells are antigen-presenting cells (APCs) which play a critical role in
More informationMultiple Myeloma and Colorectal Cancer
Multiple Myeloma and Colorectal Cancer From Systems Immunology to Single Cells Leo Hansmann Mark M. Davis Lab Department of Microbiology&Immunology Stanford University Multiple Myeloma Monoclonal disease
More informationDrug Development Services
Drug Development Services USING BLOOD AND BONE MARROW PRIMARY CELL SYSTEMS Clinically Relevant In Vitro Assays Broad Spectrum of Drug Classes Multi-Species Platforms Enhancing Drug Development through
More informationINSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance
A. Bernheim Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MyR is funded by the European Commission within its FP7 specific
More informationCell Culture Days 2015
Cell Culture Days 2015 Thursday, 07.05.2015 9:00 11:00 Tissue and 3D Cell Culture Giving cancer a shape: 3-dimensional in vitro and ex vivo lung carcinoma Katharina Leithner Organotypic cultures: Methods
More informationName (print) Name (signature) Period. (Total 30 points)
AP Biology Worksheet Chapter 43 The Immune System Lambdin April 4, 2011 Due Date: Thurs. April 7, 2011 You may use the following: Text Notes Power point Internet One other person in class "On my honor,
More informationThe Body s Defenses CHAPTER 24
CHAPTER 24 The Body s Defenses PowerPoint Lectures for Essential Biology, Third Edition Neil Campbell, Jane Reece, and Eric Simon Essential Biology with Physiology, Second Edition Neil Campbell, Jane Reece,
More informationSpecial report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006
Special report Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006 Gene And Protein The gene that causes the mutation is CCND1 and the protein NP_444284 The mutation deals with the cell
More informationHow to construct transgenic mice
How to construct transgenic mice Sandra Beer-Hammer Autumn School 2010 Bad Schandau Methods additional genetic information transgenic mouse line gene inactivation gene-deficient knockout mouse line Jak2
More informationLESSON 3.5 WORKBOOK. How do cancer cells evolve? Workbook Lesson 3.5
LESSON 3.5 WORKBOOK How do cancer cells evolve? In this unit we have learned how normal cells can be transformed so that they stop behaving as part of a tissue community and become unresponsive to regulation.
More informationMaking the switch to a safer CAR-T cell therapy
Making the switch to a safer CAR-T cell therapy HaemaLogiX 2015 Technical Journal Club May 24 th 2016 Christina Müller - chimeric antigen receptor = CAR - CAR T cells are generated by lentiviral transduction
More informationAsthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System
1 2 3 4 5 6 7 8 9 Asthma (With a little SCID to start) Lauren Smith, MD CHKD Pediatric Allergy/Immunology Disclosures None Will be discussing some medications that are not yet FDA approved Outline SCID
More informationBioMmune Technologies Inc. Corporate Presentation 2015
BioMmune Technologies Inc Corporate Presentation 2015 * Harnessing the body s own immune system to fight cancer & other autoimmune diseases BioMmune Technologies Inc. (IMU) ABOUT A public biopharmaceutical
More informationOff-target (heterologous/non-specific) effects of vaccination
Off-target (heterologous/non-specific) effects of vaccination Les Pensières Fondation Mérieux Conference Center Veyrier-du-Lac - France 8-10 June 2015 Steering Committee: Peter Aaby Michael Greenberg Ofer
More informationSTEM CELL FELLOWSHIP
Module I: The Basic Principles of Stem Cells 1. Basics of Stem Cells a. Understanding the development of embryonic stem cells i. Embryonic stem cells ii. Embryonic germ cells iii. Differentiated stem cell
More information2006 7.012 Problem Set 6 KEY
2006 7.012 Problem Set 6 KEY ** Due before 5 PM on WEDNESDAY, November 22, 2006. ** Turn answers in to the box outside of 68-120. PLEASE WRITE YOUR ANSWERS ON THIS PRINTOUT. 1. You create an artificial
More informationQUANTITATIVE APPROACHES IN CELL BIOLOGY BIOPHYSICS, BIOENGINEERING & SYSTEMS BIOLOGY
QUANTITATIVE APPROACHES IN CELL BIOLOGY BIOPHYSICS, BIOENGINEERING & SYSTEMS BIOLOGY SignGene Symposium 2014 August 31 - September 2, 2014 Max Delbrück Center for Molecular Medicine Berlin, Germany www.mdc-berlin.de/signgenesymposium2014
More informationCollaborative Research Centre 796. Reprogramming of host cells by microbial effectors. 2. International Conference
Collaborative Research Centre 796 Reprogramming of host cells by microbial effectors 2. International Conference Mechanisms of Microbial Host Cell Manipulation from Plants to Humans October 04-06. 2015
More informationANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1
AP BIOLOGY ANIMALS FORM & FUNCTION ACTIVITY #4 NAME DATE HOUR BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES Animals Form & Function Activity #4 page 1 INFLAMMATORY RESPONSE ANTIMICROBIAL
More informationFuture Oncology: Technology, Products, Market and Service Opportunities
Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter
More informationAntigenic variation in Plasmodium falciparum : Erythrocyte invasion and immune escape mechanisms
Antigenic variation in Plasmodium falciparum : Erythrocyte invasion and immune escape mechanisms Introduction Why does immunity to malaria take so long to develop? The parasite s survival depends on its
More informationXXVIIII Annual Meeting Danish Society for Neuroscience (DSfN) Stem Cells in a Neurotranslational Perspective. May 11 12; 2015
XXVIIII Annual Meeting Danish Society for Neuroscience (DSfN) Stem Cells in a Neurotranslational Perspective May 11 12; 2015 Hotel Hesselet, Nyborg Symposium organizers Morten Blinkenberg, University of
More informationAntibody Structure, and the Generation of B-cell Diversity CHAPTER 4 04/05/15. Different Immunoglobulins
Antibody Structure, and the Generation of B-cell Diversity B cells recognize their antigen without needing an antigen presenting cell CHAPTER 4 Structure of Immunoglobulin G Different Immunoglobulins Differences
More informationKMS-Specialist & Customized Biosimilar Service
KMS-Specialist & Customized Biosimilar Service 1. Polyclonal Antibody Development Service KMS offering a variety of Polyclonal Antibody Services to fit your research and production needs. we develop polyclonal
More information1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
More informationLeukemias and Lymphomas: A primer
Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes
More informationChapter 18: Applications of Immunology
Chapter 18: Applications of Immunology 1. Vaccinations 2. Monoclonal vs Polyclonal Ab 3. Diagnostic Immunology 1. Vaccinations What is Vaccination? A method of inducing artificial immunity by exposing
More informationOKT3. ~ The first mouse monoclonal antibody. used in clinical practice in the field of transplantation ~
g944202 潘 怡 心 OKT3 ~ The first mouse monoclonal antibody used in clinical practice in the field of transplantation ~ As everybody knows, OKT3 is the first mouse monoclonal antibody produced for the treatment
More informationCancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi
Cancer SBL101 James Gomes School of Biological Sciences Indian Institute of Technology Delhi All Figures in this Lecture are taken from 1. Molecular biology of the cell / Bruce Alberts et al., 5th ed.
More informationTherapeutic Systems Immunology
Therapeutic Systems Immunology Coordination: Robert Preissner, Charité, Berlin 13 Partners from Berlin (7) Göttingen (1) Heidelberg (1) Rostock (2) Tübingen (1) Overview Intro / Mission Partners Systems
More informationALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES
ALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES DESCRIPTION OF GRANT MECHANISM The Alliance for Lupus Research (ALR) is an independent,
More informationMalignant Lymphomas and Plasma Cell Myeloma
Malignant Lymphomas and Plasma Cell Myeloma Dr. Bruce F. Burns Dept. of Pathology and Lab Medicine Overview definitions - lymphoma lymphoproliferative disorder plasma cell myeloma pathogenesis - translocations
More informationControl of Gene Expression
Control of Gene Expression What is Gene Expression? Gene expression is the process by which informa9on from a gene is used in the synthesis of a func9onal gene product. What is Gene Expression? Figure
More informationDepartment of BioScience Technology Chung Yuan Christian University 2015/08/13
Department of BioScience Technology Chung Yuan Christian University 2015/08/13 Cancer Cells Cancer, the 1st leading cause of death, is an example of a disease that arises from abnormalities in cell function
More informationInteresting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA
Interesting Case Review Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA History 63 y/o male with h/o CLL for 10 years Presents with worsening renal function and hypercalcemia
More informationPh.D. in Molecular Medicine
Ph.D. in Molecular Medicine and Translational Research College of Medicine 1. Introduction: The College of Medicine, while consolidating on its undergraduate innovative educational programs, decided to
More informationUnderstanding the immune response to bacterial infections
Understanding the immune response to bacterial infections A Ph.D. (SCIENCE) DISSERTATION SUBMITTED TO JADAVPUR UNIVERSITY SUSHIL KUMAR PATHAK DEPARTMENT OF CHEMISTRY BOSE INSTITUTE 2008 CONTENTS Page SUMMARY
More informationWelcome to the Launch of Biocon s Breakthrough Innovation. For Psoriasis. Treatment
Welcome to the Launch of Biocon s Breakthrough Innovation For Psoriasis Treatment PRESS MEET Bangalore, August 10, 2013 Autoimmune Diseases are on the Rise Globally Autoimmune Disease Segment includes
More informationPublikationsliste Claudia Götz
Publikationsliste Claudia Götz 1. Reinhard,B., Götz, C., and Faillard, H.: Synthesis of N-Acetyl-9-Oacetylneuraminic acid α-p-aminophenylthioketoside and its application as ligand in the affinity chromatography
More informationJanuary 23, 2006 - SCIENTIFIC PROGRAM
January 23, 2006 - SCIENTIFIC PROGRAM Session A: MOLECULAR & CELLULAR BIOLOGY PART I Afternoon session: h. 15.00/23.00 11:00-12:30 Registration and poster positioning 13:00-14:30 Welcome Lunch 14:50-15:00
More informationNetwork Webinar Series
Undergraduate Educator Network Series Sponsored by Undergraduate Education Subcommittee SOT Education Committee June 4, 2015 12:00 Noon ET (c) SOT2015 Welcome Kristine Willett, PhD Co-Chair, C Undergraduate
More informationA disease and antibody biology approach to antibody drug discovery
A disease and antibody biology approach to antibody drug discovery Björn Frendéus, PhD VP, Preclinical research Presenter: Björn Frendéus Date: 2011-11-08 1 Antibodies have revolutionized Cancer Treatment!
More information9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium
9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) Szeged,
More informationFrom cells to therapeuticsvivalis. Humalex Fully human antibody discovery platform An integrated therapeutic development offering
From cells to therapeuticsvivalis Humalex Fully human antibody discovery platform An integrated therapeutic development offering Humalex from bench-top to clinical development The Humalex platform enables
More informationLESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES
Introduction to immunology. LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES Today we will get to know: The antibodies How antibodies are produced, their classes and their maturation processes Antigen recognition
More informationOn the origin of giant multinuclear Reed-Sternberg cells and the role of CD4 T cells in Hodgkin lymphoma
On the origin of giant multinuclear Reed-Sternberg cells and the role of CD4 T cells in Hodgkin lymphoma Uber die Entstehung von multinuklearen Reed-Sternberg Riesenzellen und die Rolle von CD4 T-Zellen
More informationWissenschaftliche Highlights der GSF 2007
H Forschungszentrum für Umwelt und Gesundheit GmbH in der Helmholtzgemeinschaft Wissenschaftlich-Technische Abteilung Wissenschaftliche Highlights der GSF 2007 Abfrage April 2007 Institut / Selbst. Abteilung
More information1 2 3 4 5 6 Figure 4.1: Gel picture showing Generation of HIV-1subtype C codon optimized env expressing recombinant plasmid pvax-1:
Full-fledged work is in progress towards construction and cloning of codon optimized envelope with subsequent aims towards immunization of mice to study immune responses. 1 2 4 5 6 Figure 4.1: Gel picture
More informationMonoclonal Antibodies in Cancer. Ralph Schwall, PhD Associate Director, Translational Oncology Genentech, Inc.
Monoclonal Antibodies in Cancer Ralph Schwall, PhD Associate Director, Translational Oncology Genentech, Inc. Disclaimer I had nothing to do with Herceptin Using lessons learned in new antibody projects
More informationSommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of
More informationImmuno-Oncology Therapies to Treat Lung Cancer
Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own
More informationEvaluation of focal adhesions as new therapeutic targets in acute myeloid leukemia
Evaluation of focal adhesions as new therapeutic targets in acute myeloid leukemia Dr Jordi Sierra Gil IRHSP Institut de Recerca Hospital de la Santa Creu i Sant Pau Dr. Miguel Ángel Sanz Alonso Fundación
More informationchronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart
Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pre- B-cell B-cell Transformed B-cell Plasma cell Ig Surface Surface Secreted Major malignant counterpart
More informationSupplemental Material CBE Life Sciences Education. Su et al.
Supplemental Material CBE Life Sciences Education Su et al. APPENDIX Human Body's Immune System Test This test consists of 31 questions, with only 1 answer to be selected for each question. Please select
More informationChimeric Antigen Receptor T Cell Therapy
Chimeric Antigen Receptor T Cell Therapy Yi Lin, MD, PhD Mayo Clinic, Rochester, MN Alliance Spring Group Meeting - May 13, 2016 Presentation Objectives l Scientific overview of chimeric antigen receptor
More informationOverview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development
Overview B cell development Transcriptional cascades Amazing aspects of lineage plasticity Conventional (B2) B cell development What happens to an autoreactive B cell? B1 vs B2 cells Key anatomical sites
More informationStemCellMathLab 2016. Systems Medicine of Leukemia
StemCellMathLab 2016 8 th International Workshop on Models and Concepts of Stem Cell Organization Systems Medicine of Leukemia June 16 th -18 th, 2016 - Hamburg, Germany Scientific Programme Thursday,
More informationChapter 8. Summary and Perspectives
Chapter 8 Summary and Perspectives 131 Chapter 8 Summary Overexpression of the multidrug resistance protein MRP1 confer multidrug resistance (MDR) to cancer cells. The contents of this thesis describe
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationA powerful model of endometrial carcinogenesis! molecular analysis and rational design of immunological intervention approaches
A powerful model of endometrial carcinogenesis! molecular analysis and rational design of immunological intervention approaches Afrouz Behboudi PhD, Associate Prof. School of Life Sciences, University
More informationIMMUNOMEDICS, 300 The American Road, Morris Plains, New Jersey 07950 (973) 605-8200 Fax (973) 605-8282
IMMUNOMEDICS, INC. 300 The American Road, Morris Plains, New Jersey 07950 (973) 605-8200 Fax (973) 605-8282 IMMUNOMEDICS ANNOUNCES FIRST QUARTER FISCAL 2014 RESULTS AND CLINICAL PROGRAM DEVELOPMENTS Morris
More information7.012 Quiz 3 practice
MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel 7.012 Quiz 3 practice Quiz 3 on Friday, November 12th
More informationCorporate Medical Policy
Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cll_and_sll
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: adoptive_immunotherapy 11/1993 3/2016 3/2017 3/2016 Description of Procedure or Service The spontaneous regression
More information